Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS - Wikidata - wikimedia - TriplyDB

Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS

Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS

http://www.wikidata.org/entity/Q27004509

about

Hepatitis C genotype 4: The past, present, and future Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion.Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes Public health and international drug policy.Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.Pegylated interferon pharmacokinetics and self-reported depressive symptoms during antiviral treatment for chronic hepatitis C.Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.Global distribution and prevalence of hepatitis C virus genotypes.Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia A public health approach to hepatitis C control in low- and middle-income countries.Clinical impact of treatment timing for chronic hepatitis C infection: a decision model High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262)Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era An Epidemiologic Investigation of a Case of Acute Hepatitis E "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model.Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa.The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.Update on HIV/HCV coinfection.HCV transmission in industrialized countries and resource-constrained areas.Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism HCV management in resource-constrained countries.Novel Humanitarian Aid Program: The Glivec International Patient Assistance Program-Lessons Learned From Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries Milestones along the road of infection prevention in Egypt.Mobilising a global response to hepatitis: Lessons learned from the HIV movement.Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection.Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus.Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for action.Rapid virological&End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis C Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?

P2860

Q26775815-565D70E9-7E71-4447-8D24-9F6665168756 Q27321791-0281EF43-24BF-4222-A89D-9712BC7BC16E Q28545971-66639310-EE5A-4493-8032-AB0B480E7B27 Q30245058-0AEE2964-BF6E-4F9B-A667-11B10A56B7F0 Q30377895-2FCC81CC-C1C0-4E64-BD31-792F06B86BA8 Q33630346-B118AE2D-DA22-44D5-99DE-90EE7CD4316E Q34262438-B972029E-9AA8-445F-82D8-708FC5B9ECBF Q34396312-85CB98F9-AA32-4480-A692-223ADEF12E30 Q34431175-C2AD389C-E6C4-4268-9FD9-E106EA337A60 Q35095416-D9D1A22C-B4F4-46CB-903A-54D83E046364 Q35164735-D41B1B1B-0591-4471-97DD-71BB3051B425 Q35889164-66218C95-B594-4278-A769-825EEA8FD73C Q36009357-7F187593-8D4A-4508-A791-6D957DF0A218 Q36133794-EF9CE16B-4FF1-41EF-BC11-F99091EB6467 Q36174043-FA8C460A-8648-41F6-AE29-9CB822C5F7A7 Q36316465-AB999FCB-B4D4-4F95-8890-CD77B8560823 Q36750449-84287CE1-D35D-4CBA-BD7B-0A8E08DC36ED Q36995882-5D8DBEAB-724C-45FE-811B-A74BA33B2390 Q37486425-8342E1A3-E690-4D55-93FA-4641198CE3F3 Q38119893-EA53A5C6-B93D-4018-BA8C-9481FD9ECF4E Q38147886-69B9CAC9-E325-42ED-B9D2-47BB6B0F95F2 Q38302103-564331D9-4BC2-4082-BC57-98A1D52D91A2 Q38372939-7677DEF5-EE13-48F1-B9B0-D83940DF9323 Q38386664-AA89DF2F-8A7D-4ECC-A453-3F8EA36E1944 Q38558433-AF6A63AE-13F2-423B-AB7B-8215EB856C7F Q38810895-452766EE-AC6C-4BBD-9E4B-589CB8287D68 Q38821075-D186073F-5442-4187-943F-E1A81983CBD8 Q38932103-62ECDB58-79F9-42BD-9EBE-64331FD2E88B Q39315202-5BDAA309-D791-484D-89ED-2696FA4674ED Q41104253-D815EFC5-5429-4830-84F8-FB6B0042FF68 Q42249024-C2DB9E6A-4F82-4EEB-A7A3-31B5BFE5AD1D Q42669690-31C32FB5-9083-45D1-BFB3-03678C9A9967 Q50041788-C6D36DC8-175A-4F62-ADED-B60AA042BECE Q52597017-3C675310-8A38-4CFB-BFF6-08886195C4AD

P2860

Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS

http://www.wikidata.org/entity/Q27004509

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@ast

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@en

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@nl

type

label

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@ast

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@en

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@nl

prefLabel

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@ast

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@en

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@nl

P1433

Q27004509-2F88AC0D-4E8B-4705-B546-62F9BA7B0C63

P1476

Q27004509-D7BF3DF3-533B-4D52-8615-236FED2DCD95

P2093

Q27004509-702CC3BF-1E55-4E15-8B55-AC9278713592

Q27004509-856DFDEE-DD13-423C-AEAB-7B1EF2A9FB8A

Q27004509-8745585C-2DE0-4AA3-A803-4E6DFEB9CB76

Q27004509-B38F6718-369B-4F61-926B-05777039A27A

Q27004509-E5D892E7-C75F-4C82-BF44-E48AE65ADB24

P2860

Q27004509-005FE2BB-201C-4D23-888C-857EC88DE057

Q27004509-08754A7E-2277-4720-8980-6EDED0DFB9F3

Q27004509-0B8F3BD7-B346-4F1C-89D9-9D76B516C3CD

Q27004509-122CBC33-63ED-43A4-9084-81DF438D9902

Q27004509-173A4AB4-FFC5-4B3A-A795-81B275E6D6F8

Q27004509-2C9F2C03-4BD7-450F-968A-C78E33279393

Q27004509-358ACBE0-06BA-4BD8-B2ED-447BD573451D

Q27004509-454C8183-E3FE-4F5A-A9F3-C742F348839B

Q27004509-48807461-7CA3-4E78-872D-BEC4006CF81B

Q27004509-4942B323-D30A-4B36-A752-E3F8659EB5D7

P304

Q27004509-432512DC-6247-4723-A95F-60D1894C590F

P31

Q27004509-FA2684FC-AA40-4ABF-9E52-67645996AB55

P3181

Q27004509-D9BDC583-4F66-42FB-ABD9-EE6153E0E6D2

P356

Q27004509-172279C6-E4D8-4A23-955A-B62D43D8BBA2

P407

Q27004509-FC61428B-2D78-4EA7-94C8-3F7EBE28EBC9

P433

Q27004509-6D289C4E-ACA6-4C5A-AC35-7A57FB31A207

P478

Q27004509-F613A437-1C2E-462E-9E5E-ED0F3660A7A2

P50

Q27004509-6690EEA5-8550-499A-8CB7-D7B5BAEF09EF

Q27004509-76767230-F2D3-4427-867A-140511069FF1

P577

Q27004509-5FE8465D-66BB-4C43-B70F-2C9793369B4F

P5875

Q27004509-31A16577-08F2-42C0-BC58-4C1F0A1238D9

P698

Q27004509-A389BDA8-A6A6-4C06-972A-039154694A92

P921

Q27004509-29C38810-4C12-4693-A79E-736267BC75C5

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Expanding access to treatment ...... ettings: lessons from HIV/AIDS

@en

P2093

Adeeba Kamarulzaman

http://www.w3.org/2001/XMLSchema#string

Edward J Mills

http://www.w3.org/2001/XMLSchema#string

Kasha Singh

http://www.w3.org/2001/XMLSchema#string

Nathan Ford

http://www.w3.org/2001/XMLSchema#string

Philipp du Cros

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes of treatment for hepatitis C virus infection by primary care providers

Global epidemiology of hepatitis C virus infection

HIV prevention before HAART in sub-Saharan Africa.

Redesigning the AIDS response for long-term impact.

Non-invasive markers for hepatic fibrosis

Non-invasive assessment of liver fibrosis in chronic hepatitis C.

'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.

A systematic review of task- shifting for HIV treatment and care in Africa

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.

Prisons as social determinants of hepatitis C virus and tuberculosis infections.

P304

1465-1472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

903457

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/CID/CIS227

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Tido von Schoen-Angerer

P577

2012-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221724393

http://www.w3.org/2001/XMLSchema#string

P698

22431808

http://www.w3.org/2001/XMLSchema#string

P921